Neurocrine Biosciences Inc
NASDAQ:NBIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neurocrine Biosciences Inc
NASDAQ:NBIX
|
US |
|
Societe Generale SA
PAR:GLE
|
FR |
|
Mphasis Ltd
NSE:MPHASIS
|
IN |
|
MGP Ingredients Inc
NASDAQ:MGPI
|
US |
|
W
|
Walgreens Boots Alliance Inc
XETRA:W8A
|
US |
|
C
|
Cars.com Inc
LSE:0HTZ
|
US |
|
Galaxy Entertainment Group Ltd
F:KW9A
|
HK |
|
B
|
Brown-Forman Corp
SWB:BF5B
|
US |
|
P
|
Pine Cliff Energy Ltd
TSX:PNE
|
CA |
|
Gecina SA
OTC:GECFF
|
FR |
|
J
|
Jyske Bank A/S
SWB:JYS1
|
DK |
|
G
|
Glenmark Pharmaceuticals Ltd
BSE:532296
|
IN |
|
Quanta Computer Inc
TWSE:2382
|
TW |
|
L
|
Lagardere SA
XHAM:LAG
|
FR |
|
Catena AB
LSE:0GVS
|
SE |
|
T
|
Tubacex SA
SWB:TCX
|
ES |
|
Heian Ceremony Service Co Ltd
TSE:2344
|
JP |
|
M
|
Mondi PLC
DUS:KYC
|
UK |
Shareholder Yield
Current shareholder yield for NBIX is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
NBIX Price
Neurocrine Biosciences Inc
| Average Annual Return | 10.83% |
| Standard Deviation of Annual Returns | 17.98% |
| Max Drawdown | -32% |
| Market Capitalization | 15.9B USD |
| Shares Outstanding | 100 360 000 |
| Percentage of Shares Shorted | 7.76% |
